Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A specific, sensitive radioimmunoassay for platelet-activating factor (PAF).

M A Smal1, B A Baldo, A McCaskill

  • 1Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, NSW, Australia.

Journal of Immunological Methods
|April 17, 1990
PubMed
Summary

A novel radioimmunoassay (RIA) for platelet-activating factor (PAF) offers high sensitivity and specificity. This assay simplifies PAF measurement compared to traditional bioassays, reducing variability and increasing capacity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of the process of implementation of ISO 7101 subclause 8.10.5 Health literacy in specialty consultations.

Journal of healthcare quality research·2024
Same author

Validation of the Spanish version of the Health Literacy Survey (HLS<sub>19</sub>-Q12) in secondary care specialty consultations.

Public health·2024
Same author

Sugammadex and hypersensitivity.

Anaesthesia and intensive care·2014
Same author

Sugammadex and anaphylaxis in the operating theater.

Revista espanola de anestesiologia y reanimacion·2014
Same author

Cross-reactive antigens for natural IgE antibodies: allergens with the potential to transform a dormant to an active allergic response?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
Same author

The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?

Mini reviews in medicinal chemistry·2012

Area of Science:

  • Biochemistry
  • Immunology
  • Analytical Chemistry

Background:

  • Platelet-activating factor (PAF) is a potent lipid mediator involved in various physiological and pathological processes.
  • Accurate quantification of PAF is crucial for understanding its role in inflammation, allergy, and thrombosis.
  • Existing bioassays for PAF are often complex, variable, and have limited capacity.

Purpose of the Study:

  • To develop and validate a specific and sensitive radioimmunoassay (RIA) for platelet-activating factor (PAF).
  • To compare the performance characteristics of the developed RIA with existing PAF bioassays.

Main Methods:

  • Development of a radioimmunoassay utilizing specific anti-PAF antibodies.
  • Antibody specificity was tested against PAF, lyso-PAF, lecithin, and lysolecithin.

Related Experiment Videos

  • Sensitivity was determined over a range of 10-1000 pg (0.02-2 pmol).

    • Main Results:

    • The developed RIA demonstrated high sensitivity for PAF detection, ranging from 10-1000 pg.
    • Anti-PAF antibodies exhibited specific binding to the acetyl group at the C2 position of PAF.
    • No significant cross-reactivity was observed with lyso-PAF or other natural lipids.
    • The RIA offered comparable or better sensitivity than platelet-based bioassays.
    • The RIA was simpler, had higher capacity, and reduced variability compared to bioassays.

    Conclusions:

    • A specific and sensitive radioimmunoassay for platelet-activating factor (PAF) has been successfully developed.
    • This RIA offers significant advantages over traditional bioassays, including simplicity, higher capacity, and reduced variability.
    • The RIA provides a robust tool for accurate PAF quantification in research and clinical settings.